---
$id: https://graph.org.ai/products/commodity/51162650
$type: Product
source: UNSPSC
code: "51162650"
title: "Xyloxemine"
class: "51162600"
classTitle: "Antitussives and associated cough remedies"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Xyloxemine

**UNSPSC Code**: 51162650
**Class**: [Antitussives and associated cough remedies](Antitussives and associated cough remedies.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antitussive agent with the molecular formula C23H33NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) L95KV83PV9, chemically known as 2-(2-(di-2,6-xylylmethoxy)ethoxy)-n,n-dimethylethylamine but more generally known as xyloxemine, which bears US NIH Compound Identifier 17800. European Medicines Agency schedules Xyloxemine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00123MIG. The term XYLOXEMINE is an International Non-Proprietary Name. XYLOXEMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule xyloxemine under HS 29221980 and SITC 51461. As of Q4 2014, XYLOXEMINE remains US FDA's Preferred Term for this commodity. Xyloxemine bears US NLM identifiers UMLS ID C1883581 and NCI Concept Code C66675. SMILES: O(C(C1C(CCCC1C)C)C1C(CCCC1C)C)CCOCCN(C)C.

